4 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Cushing Disease: new trials by email Literature Review of Cushing Disease trials Research Report on Cushing Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and PK of CRN04894 for the Treatment of Cushing's Syndrome atumelnant - Cushing Syndrome, Cushing Disease | Phase 1 / Phase 2 | Completed | Crinetics Pharmaceuticals Inc. | 19 | 2023-10-12 | 2026-10-14 |
| Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease Seliciclib - Cushing Disease | Phase 2 | Completed | Cedars-Sinai Medical Center | 5 | 2018-11-02 | 2026-10-16 |
| Safety and Efficacy of LCI699 in Cushing's Disease Patients LCI699 - Cushings Disease, Cushing Disease | Phase 2 | Completed | Novartis Pharmaceuticals | 31 | 2011-03-23 | 2021-01-22 |
| Extension Study to Assess the Safety and Efficacy of Pasireotide in Participants With Cushing's Disease Pasireotide - Cushing Disease | Phase 2 | Completed | Novartis Pharmaceuticals | 19 | 2004-08-13 | 2021-06-02 |
Pituitary ACTH Hypersecretion (4) · ACTH Syndrome, Ectopic (1) · Adrenocortical Hyperfunction (1) · Cushing Syndrome (1) · Pituitary Diseases (1)
Brain Diseases (4) · Central Nervous System Diseases (4) · Endocrine System Diseases (4) · Hyperpituitarism (4) · Hypothalamic Diseases (4) · Nervous System Diseases (4) · Pituitary Diseases (3) · Adrenal Gland Diseases (2) · Adrenocortical Hyperfunction (1) · Neoplasms (1) · Paraneoplastic Endocrine Syndromes (1) · Paraneoplastic Syndromes (1)
Osilodrostat (1) · Roscovitine (1) · pasireotide (1)
Novartis Pharmaceuticals (2) · Cedars-Sinai Medical Center (1) · Crinetics Pharmaceuticals Inc. (1)
United States (4) · France (2) · Italy (2) · Germany (1) · Japan (1) · United Kingdom (1)
Ning-Ai Liu, MD, PhD (1) · Shlomo Melmed, MD (1)
PMID 23943009, PMID 24423285, PMID 41052284
2004 (1)